Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Inzinger Martin |

** = Publications listed in SCI/SSCI/Pubmed

2023

Full paper/article (Journal)

** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Zikeli, C; Gruber, B; Sator, P; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Sassmann, C; Painsi, C; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Inzinger, M; Bangert, C; Ellersdorfer, C; Falkensteiner, K; Sadoghi, B; Gruber-Wackernagel, A; Hofer, A; Legat, F; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hötzenecker, W; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022.
J Dtsch Dermatol Ges. 2023; 21(12): 1513-1523. Doi: 10.1111/ddg.15213
Web of Science PubMed FullText FullText_MUG

 

** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Zikeli, C; Gruber, B; Sator, P; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Sassmann, C; Painsi, C; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Inzinger, M; Bangert, C; Ellersdorfer, C; Falkensteiner, K; Sadoghi, B; Gruber-Wackernagel, A; Hofer, A; Legat, F; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hötzenecker, W; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022.
J Dtsch Dermatol Ges. 2023; 21(12): 1513-1523. Doi: 10.1111/ddg.15213_g
Web of Science PubMed FullText FullText_MUG

 

2021

Full paper/article (Journal)

** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Kölli, C; Gruber, B; Sator, PG; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Painsi, C; Selhofer, S; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Tanew, A; Inzinger, M; Tatarski, R; Bangert, C; Ellersdorfer, C; Lichem, R; Gruber-Wackernagel, A; Hofer, A; Legat, F; Schmiedberger, E; Strohal, R; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hoetzenecker, W; Trautinger, F; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.
Br J Dermatol. 2021; 184(6):1094-1105 Doi: 10.1111/bjd.19701 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Short report/Letter

** Painsi, C; Schmid-Zalaudek, K; Weger, W; Hofmann-Wellenhof, R; Wolf, P; Lackner, HK; Fink-Puches, R; Inzinger, M; Gruber, B; Krenmayr, K; Mlynek, A; Ahlgrimm-Siess, V; Salmhofer, W Teledermatological assessment of one psoriasis target lesion and patient-reported-PASI are sufficient for psoriasis monitoring.
J Dtsch Dermatol Ges. 2021; 19(7):1064-1066 Doi: 10.1111/ddg.14468
Web of Science PubMed FullText FullText_MUG

 

** Painsi, C; Schmid-Zalaudek, K; Weger, W; Hofmann-Wellenhof, R; Wolf, P; Lackner, HK; Fink-Puches, R; Inzinger, M; Gruber, B; Krenmayr, K; Mlynek, A; Ahlgrimm-Siess, V; Salmhofer, W Die Teledermatologische Beurteilung einer Psoriasis-Zielläsion und der vom Patienten selbst berechnete PASI sind suiffizient für das Psoriasis-Monitoring.
J Dtsch Dermatol Ges. 2021; 19(7):1064-1066 Doi: 10.1111/ddg.14468_g
PubMed FullText FullText_MUG

 

2017

Abstract (Journal)

** Wolf, P; Weger, W; Richter, L; Mlynek, A; Sator, P; Saxinger, W; Ratzinger, G; Kolli, C; Painsi, C; Bangert, C; Tatarski, R; Schutz-Bergmayr, M; Ponholzer, P; Trautinger, F; Strohal, R; Mullegger, R; Inzinger, M; Lichem, R; Salmhofer, W; Quehenberger, F Switching or restarting of tumour necrosis factor-alpha inhibitors after interruption under daily-life conditions: efficacy report from the Austrian Psoriasis Registry (PsoRA)
BRIT J DERMATOL. 2017; 177(5): E250-E250. [Oral Communication]
Web of Science

 

2016

Full paper/article (Journal)

** Inzinger, M; Wippel-Slupetzky, K; Weger, W; Richter, L; Mlynek, A; Fleischander, B; Scheurecker, C; Sandor, N; Mairhofer, D; Sator, PG; Moser-Oberthaler, S; Häring, N; Viznerova, P; Painsi, C; Tanew, A; Ponholzer, P; Tatarski, R; Brenner, W; Stingl, G; Salmhofer, W; Rappersberger, K; Klein, G; Saxinger, W; Auböck, J; Kölli, C; Trautinger, F; Steiner, A; Ratzinger, G; Strohal, R; Riedl, E; Lange-Asschenfeldt, B; Pehamberger, H; Volc-Platzer, B; Selhofer, S; Legat, FJ; Müllegger, R; Reider, N; Schmuth, M; Hintner, H; Hofer, A; Gruber-Wackernagel, A; Aberer, W; Quehenberger, F; Wolf, P Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.
Acta Derm Venereol. 2016; 96(2):207-212 Doi: 10.2340/00015555-2214 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Full paper/article (Journal)

** Painsi, C; Patscheider, M; Inzinger, M; Lange-Asschenfeldt, B; Quehenberger, F; Wolf, P Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.
J Dtsch Dermatol Ges. 2015; 13(11):1156-1163 Doi: 10.1111/ddg.12820
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Painsi, C; Patscheider, M; Inzinger, M; Huegel, R; Lange-Asschenfeldt, B; Quehenberger, F; Wolf, P Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions.
Br J Dermatol. 2015; 173(3):815-817 Doi: 10.1111/bjd.13744
Web of Science PubMed FullText FullText_MUG

 

2014

Full paper/article (Journal)

** Holzer, M; Wolf, P; Inzinger, M; Trieb, M; Curcic, S; Pasterk, L; Weger, W; Heinemann, A; Marsche, G Anti-psoriatic therapy recovers high-density lipoprotein composition and function.
J Invest Dermatol. 2014; 134(3):635-642 Doi: 10.1038/jid.2013.359 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Koller, S; Inzinger, M; Rothmund, M; Ahlgrimm-Siess, V; Massone, C; Arzberger, E; Wolf, P; Hofmann-Wellenhof, R UV-induced alterations of the skin evaluated over time by reflectance confocal microscopy.
J Eur Acad Dermatol Venereol. 2014; 28(8):1061-1068 Doi: 10.1111/jdv.12284
Web of Science PubMed FullText FullText_MUG

 

** Oliveira, A; Inzinger, M; Hofmann-Wellenhof, R [Peripheral streaks or leaf-like structures--that's the question].
Hautarzt. 2014; 65(2):146-147 Doi: 10.1007/s00105-013-2731-x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Inzinger, M; Legat, FJ; Hofer, A; Weger, W; Gruber-Wackernagel, A; Salmhofer, W; Wolf, P Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agents.
Br J Dermatol. 2014; 171(4):915-917 Doi: 10.1111/bjd.12992
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Inzinger, M; Weger, W; Wippel-Slupetzky, K; Fleischanderl, B; Richter, L; Mlynek, A; Viznerova, P; Scheurecker, C; Sandor, N; Haring, N; Sator, P; Tatarski, R; Tanew, A; Painsi, C; Mairhofer, D; Moser-Oberthaler, S; Ponholzer, P; Brenner, W; Salmhofer, W; Stingl, G; Saxinger, W; Rappersberger, K; Klein, G; Riedl, E; Aubock, J; Kolli, C; Strohal, R; Steiner, A; Selhofer, S; Pehamberger, H; Lange-Asschenfeldt, B; Trautinger, F; Reider, N; Vloc-Platzer, B; Legat, FJ; Mullegger, R; Hintner, H; Ratzinger, G; Schmuth, M; Hofer, A; Gruber-Wackernagel, A; Aberer, W; Quehenberger, F; Wolf, P Drug adherence to ustekinumab in the treatment of plaque psoriasis under daily life conditions: report from the Psoriasis Registry Austria
BRIT J DERMATOL. . 2014; 171(6):E168-E168.-7th International Congress of Psoriasis - From Gene to Clinic; DEC 11-13, 2014; London, ENGLAND. [Poster]
Web of Science

 

2013

Full paper/article (Journal)

** Inzinger, M; Massone, C; Arzberger, E; Hofmann-Wellenhof, R Hair repigmentation in melanoma.
Lancet. 2013; 382(9899):1224-1224 Doi: 10.1016/S0140-6736(13)61604-9 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Inzinger, M; Tilz, H; Komericki, P; Schuster, C; Wolf, P; Kränke, B Heat-triggered reticular telangiectatic erythema induced by a spinal cord stimulator.
Mayo Clin Proc. 2013; 88(1):117-119 Doi: 10.1016/j.mayocp.2012.10.019 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Inzinger, M; Weger, W; Heschl, B; Salmhofer, W; Quehenberger, F; Wolf, P Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.
J Eur Acad Dermatol Venereol. 2013; 27(7):861-866 Doi: 10.1111/j.1468-3083.2012.04596.x
Web of Science PubMed FullText FullText_MUG

 

Case Report

** Tilz, H; Becker, JC; Legat, F; Schettini, AP; Inzinger, M; Massone, C Allopurinol in the treatment of acquired reactive perforating collagenosis.
An Bras Dermatol. 2013; 88(1):94-97 Doi: 10.1590/s0365-05962013000100012 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Full paper/article (Journal)

** Holzer, M; Wolf, P; Curcic, S; Birner-Gruenberger, R; Weger, W; Inzinger, M; El-Gamal, D; Wadsack, C; Heinemann, A; Marsche, G Psoriasis alters HDL composition and cholesterol efflux capacity.
J Lipid Res. 2012; 53(8):1618-1624 Doi: 10.1194/jlr.M027367 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Inzinger, M; Weger, W; Salmhofer, W; Wolf, P Differential Response of Chronic Plaque Psoriasis to Briakinumab vs. Ustekinumab.
Acta Derm Venereol. 2012; 92(4):357-358 Doi: 10.2340/00015555-1243 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Wolf, P; Weger, W; Legat, FJ; Posch-Fabian, T; Gruber-Wackernagel, A; Inzinger, M; Salmhofer, W; Hofer, A Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial.
Br J Dermatol. 2012; 166(1):147-153 Doi: 10.1111/j.1365-2133.2011.10616.x
Web of Science PubMed FullText FullText_MUG

 

Review

** Inzinger, M; Salmhofer, W; Binder, B Neonatal lupus erythematosus and its clinical variability.
J Dtsch Dermatol Ges. 2012; 10(6): 407-411. Doi: 10.1111/j.1610-0387.2012.07940.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Inzinger, M; Roschatt, I; Weger, W; Salmhofer, W; Wolf, P; Intermediate to long-term efficacy and safety of etanercept: report from the psoriasis registry Austria.
J INVEST DERMATOL. 2012; 132: S60-S60.-42nd Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 07-10, 2012; Venice, ITALY. [Poster]
Web of Science

 

2011

Full paper/article (Journal)

** Inzinger, M; Heschl, B; Weger, W; Hofer, A; Legat, FJ; Gruber-Wackernagel, A; Tilz, H; Salmhofer, W; Quehenberger, F; Wolf, P Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
Br J Dermatol. 2011; 165(3):640-645 Doi: 10.1111/j.1365-2133.2011.10396.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Inzinger, M; Kränke, B; Binder, B Acquired zinc deficiency due to long-term tube feeding.
Eur J Dermatol. 2011; 21(4): 633-634. Doi: 10.1684/ejd.2011.1408 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Inzinger, M; Heschl, B; Weger, W; Gruber-Wackernagel, A; Legat, FJ; Hofer, A; Kokol, R; Tilz, H; Salmhofer, W; Quehenberger, F; Wolf, P Efficacy of methotrexate versus fumaric acid esters administered under daily life conditions in moderate to severe chronic plaque psoriasis
J INVEST DERMATOL. 2011; 131: S45-S45.-41st Annual Meeting of the European-Society-for-Dermatological-Research; SEP 07-10, 2011; Barcelona, SPAIN.
Web of Science

 

** Tilz, H; Inzinger, M; Weger, W; Gehrer, M; Aberer, E; Ginter-Hanselmayer, G Rare Coexistence of Sarcoidosis and Tuberculosis
J DTSCH DERMATOL GES. 2011; 9: 224-224.-Deutsche Dermatologische Gesellschaft; 30. März bis 2. April 2011 ; Dresden / Deutschland. [Poster]
Web of Science

 

2010

Abstract (Journal)

** Inzinger, M; Heschl, B; Weger, W; Hofer, A; Legat, F; Gruber-Wackernagel, A; Salmhofer, W; Wolf, P Efficacy of PUVA therapy compared with biologics in moderate to severe chronic plaque psoriasis
J Invest Dermatol. JID 2010; Abstracts from the 40th Annual Meeting of the European Society for Dermatological Research.2010; 130: S55-S55.-40th Annual Meeting of the European Society for Dermatological Research ; Sep 8-11, 2010; Helsinki, FINLAND. [Oral Communication]
Web of Science

 

** Weger, W; Hofer, A; Legat, FJ; Posch-Fabian, T; Gruber-Wackernagel, A; Inzinger, M; Salmhofer, W; Wolf, P UVB-311nm advances the clearance of psoriatic lesions in ustekinumab-treated patients
J INVEST DERMATOL. 2010; 130: S48-S48. [Poster]
Web of Science

 

© Med Uni GrazImprint